Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANGIODYNAMICS INC Director's Dealing 2025

Jul 22, 2025

32939_dirs_2025-07-22_50275345-4fc0-45ed-924f-e991cf71bc1d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2025-07-19

Reporting Person: Campbell Chad Thomas (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-07-19 Common Stock F 1025 $8.69 Disposed 93051 Direct
2025-07-20 Common Stock F 359 $8.69 Disposed 92692 Direct
2025-07-21 Common Stock F 395 $8.99 Disposed 92297 Direct

Footnotes

F1: The exempt disposition of 1,025 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2023.

F2: The exempt disposition of 359 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.

F3: The exempt disposition of 395 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 21, 2021.